Cara's Therapeutics oral difelikefalin as adjunct therapy to TCS did not demonstrate a meaningful clinical benefit compared to TCS alone. Among CARA's 3 late-stage programs, investors perhaps had the ...
Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results